Clinical Outcomes in Chronic Lymphocytic Leukaemia Associated With Expression of CD5, a Negative Regulator of B-Cell Receptor Signalling

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15632
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Clinical Characteristics of B-Cell Lymphoma-Associated Hemophagocytic Syndrome (B-Lahs): Comparison of CD5+ With CD5- B-Lahs.

Internal Medicine
Internal MedicineMedicine
2001English

Chronic Lymphocytic Leukaemia: The Role of T Cells in a B Cell Disease

British Journal of Haematology
Hematology
2019English

Early Response Gene Signalling in Bryostatin-Stimulated Primary B Chronic Lymphocytic Leukaemia Cells in Vitro

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1996English

Corrigendum: Signalling Thresholds and Negative B-Cell Selection in Acute Lymphoblastic Leukaemia

Nature
Multidisciplinary
2016English

Second Malignancies in B-Cell Chronic Lymphocytic Leukaemia: Possible Association With Human Papilloma Virus

British Journal of Haematology
Hematology
2010English

Thiamine Deficiency in Patients With B-Chronic Lymphocytic Leukaemia: A Pilot Study

Postgraduate Medical Journal
Medicine
2001English

Chronic Active B-Cell-Receptor Signalling in Diffuse Large B-Cell Lymphoma

Nature
Multidisciplinary
2010English

Chronic Lymphocytic Leukaemia

Nature Reviews Disease Primers
Medicine
2017English

Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy